Avita Medical | 1811094D - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
Accuray USD 53.42M 8.45M 2025-12
Celltrion KRW 434.82B 1.14B 2026-03
Clinuvel Pharmaceuticals AUD 249.02M 8.21M 2025-12
Cochlear AUD 1.94B 12.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Mayne Pharma AUD 454.19M 93.58M 2024-06
Medical Developments International AUD 54.77M 335K 2025-12
Nanosonics AUD 219.69M 9.78M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 371.81M 2.36M 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pacific Edge NZD 10.66M 16.24M 2026-06
Paradigm Biopharmaceuticals AUD 6M 15.18M 2025-12
Pharma Mar EUR 249.67M 2.16M 2026-03
Polynovo AUD 83.14M 121K 2025-12
PYC Therapeutics AUD 147.18M 22.82M 2025-12
Qiagen NV USD 3.33B 446.45M 2026-03
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.49B 171.03M 2026-03
Sartorius EUR 2.82B 96.3M 2026-06
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Telix Pharmaceuticals AUD 416.86M 5.08M 2025-12
Tilray USD 1.58B 39.08M 2025-09
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03